Clinical trial
Clinical Utility of an Age, Sex and Gene Expression Score (ASGES or Corus CAD) in the Diagnostic Management of Obstructive Coronary Artery Disease in African American Patients in a Primary Care Setting
NCT02405754 is registered in ClinicalTrials.gov with CardioDx as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Utility of an Age, Sex and Gene Expression Score (ASGES or Corus CAD) in the Diagnostic Management of Obstructive Coronary Artery Disease in African American Patients in a Primary Care Setting
- Lead sponsor
- CardioDx
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- August 31, 2014
- Enrollment
- 667 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
angina pectoris, cad, cardiovascular diseases, chd, chest pain, coronary artery disease, coronary heart disease, cvd